(Q38203301)

30 August 2017

title

A review of clinical aspects of breast cancer (English)

1 reference

30 August 2017

1 reference

2

Marc Lippman

1 reference

30 August 2017

Shai Libson

1

1 reference

30 August 2017

publication date

1 February 2014

1 reference

International Review of Psychiatry

30 August 2017

published in

1 reference

30 August 2017

volume

26

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

4-15

1 reference

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Effect of three decades of screening mammography on breast-cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Breast cancer after use of estrogen plus progestin in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Risk of ischemic heart disease in women after radiotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

A new genome-driven integrated classification of breast cancer and its implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Genetic predisposition syndromes and their management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Effect of depression on diagnosis, treatment, and survival of older women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Central obesity and breast cancer risk: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Breast cancer after treatment of Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Alcohol and Breast Cancer in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Depression and cancer: mechanisms and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

EXTENDED RADICAL MASTECTOMY FOR BREAST CANCER.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Trastuzumab emtansine for HER2-positive advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

Long-term results of hypofractionated radiation therapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.852971

10.3109/09540261.2013.852971

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference